Valproic acid and lamotrigine treatment during pregnancy - The risk of chromosomal abnormality


Ozkinay F. F. , COGULU O. , GUNDUZ C. , YILMAZ D., KULTURSAY N.

MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS, cilt.534, ss.197-199, 2003 (SCI İndekslerine Giren Dergi)

  • Cilt numarası: 534
  • Basım Tarihi: 2003
  • Doi Numarası: 10.1016/s1383-5718(02)00254-1
  • Dergi Adı: MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS
  • Sayfa Sayısı: ss.197-199

Özet

A baby bom to an epileptic mother had dysmorphological features associated with 47,XXX karyotype, The mother had been treated with valproic acid (1800 mg per day) and lamotrigine (100 mg per day) throughout pregnancy. Dysmorphological features detected in baby were intrauterine growth retardation, hypertelorism, flattened nasal bridge, low set malformed auriculas, micrognathia, very small an bow-shaped mouth with thin upper lip, cleft palate, arachnodactyly, camptodactyly, secundum atrial septal defect, bilateral hammer toes and decreased creases on the soles. At 6 months old she showed motor retardation. The molecular analysis of parents revealed that extra X chromosome was inherited from the mother. In this case whether the dysmorphological features and 47,XXX karyotype were caused by lamotrigine and valproic acid treatment during pregnancy or coincidence is in question. (C) 2002 Elsevier Science B.V. All rights reserved.